DETERMINATION OF SERUM INFLIXIMAB LEVELS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE, COMPARISON OF POINT-OF-CARE AND ELISA IMMUNOASSAY

被引：0
|
作者：
Burti, C. [1 ]
Ciafardini, C. [1 ]
Mazza, S. [1 ]
Scaramella, L. [1 ]
Vecchi, M. [1 ]
Caprioli, F. A. [1 ]
机构：
[1] Fdn IRCCS Ca Granda Osped Maggiore Policlin Milan, Milan, Italy
来源：
DIGESTIVE AND LIVER DISEASE | 2020年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
T04.01.22
引用
收藏
页码：S126 / S126
页数：1
相关论文
共 50 条
  • [31] Development of a new immunoassay for the accurate determination of anti-infliximab antibodies in inflammatory bowel disease
    Semmler, J. M.
    Pilch, A.
    Armbruster, F. P.
    Dignass, A.
    Kruis, W.
    Stein, J.
    [J]. JOURNAL OF CROHNS & COLITIS, 2014, 8 : S41 - S41
  • [32] Validation of a Point-of-Care Quantitative Equine IgG Turbidimetric Immunoassay and Comparison of IgG Concentrations Measured with Radial Immunodiffusion and a Point-of-Care IgG ELISA
    Ujvari, S.
    Schwarzwald, C. C.
    Fouche, N.
    Howard, J.
    Schoster, A.
    [J]. JOURNAL OF VETERINARY INTERNAL MEDICINE, 2017, 31 (04): : 1170 - 1177
  • [33] Use of a point-of-care screening tool to identify depression and anxiety in patients with inflammatory bowel disease
    Karpin, J.
    Rodriguez, T.
    Traboulsi, C.
    Rai, V.
    Rubin, D.
    [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S272 - S273
  • [34] Point-of-care ultrasound accurately quantifies skeletal muscle index in patients with Inflammatory Bowel Disease
    Nguyen, A.
    Burns, M.
    Lambell, K.
    Holt, D.
    Herath, M.
    Gibson, P. R.
    Ebeling, P.
    Milat, F.
    Moore, G.
    [J]. JOURNAL OF CROHNS & COLITIS, 2022, 16 : I240 - I241
  • [35] USE OF A POINT-OF-CARE SCREENING TOOL TO IDENTIFY DEPRESSION AND ANXIETY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Karpin, Jordan
    Rodriguez, Tina G.
    Traboulsi, Cindy
    Rai, Victoria
    Rubin, David T.
    [J]. GASTROENTEROLOGY, 2020, 158 (06) : S425 - S425
  • [36] Comparative study of a point-of-care test and an enzyme-linked immunosorbent assay (ELISA) for infliximab levels
    Thunberg, Joel
    Granno, Olle
    Bergemalm, Daniel
    Eriksson, Carl
    Visuri, Isabella
    Eberhardson, Michael
    Halfvarson, Jonas
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2024, 59 (02) : 150 - 155
  • [37] Impact of Antibodies to Infliximab on Clinical Outcomes and Serum Infliximab Levels in Patients With Inflammatory Bowel Disease (IBD): A Meta-Analysis
    Nanda, Kavinderjit S.
    Cheifetz, Adam S.
    Moss, Alan C.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 (01): : 40 - 47
  • [38] Pharmacist-Driven Therapeutic Infliximab Monitoring at the Point of Care Using Rapidly Assessed Drug Levels in Patients with Inflammatory Bowel Disease
    Rentsch, Clarissa A.
    Ward, Mark G.
    Luber, Raphael P.
    Taylor, Kirstin M.
    Gibson, David J.
    Headon, Belinda
    Rosella, Ourania
    Su, Heidi Y.
    Friedman, Antony B.
    Dooley, Michael
    Sparrow, Miles P.
    Gibson, Peter R.
    [J]. THERAPEUTIC DRUG MONITORING, 2023, 45 (03) : 383 - 391
  • [39] Relationship Between Serum Trough Infliximab Levels and Serum Albumin in Patients With Inflammatory Bowel Diseases
    Malickova, Karin
    Duricova, Dana
    Bortlik, Martin
    Brodska, Helena
    Janatkova, Ivana
    Zima, Tomas
    Komarek, Viktor
    Machkova, Nadezda
    Lukas, Milan
    [J]. GASTROENTEROLOGY, 2011, 140 (05) : S282 - S282
  • [40] Rapid point-of-care monitoring of anti-infliximab antibodies in patients with inflammatory bowel disease treated with the reference infliximab or CT-P13 in routine clinical practice
    Ametzazurra, A.
    Rivera, N.
    Hernandez, A. M.
    Arreba, M. P.
    Ruiz, E.
    Ortiz, J.
    Munoz, M. D. C.
    Torres, N.
    Pascual, J.
    Martinez, A.
    Allande, M. J.
    Nagore, D.
    [J]. JOURNAL OF CROHNS & COLITIS, 2017, 11 : S335 - S336
12345